Article PDF
Avoid common mistakes on your manuscript.
References
Aisen PS. Pre-Dementia Alzheimer’s Trials: Overview. J Nutr Health Aging. 2010;14(4):294
Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer’spathological cascade. Lancet Neurol. 2010 Jan;9(1):119–128
Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol. 2006 Mar;59(3):512–519.
Schneider LS. The Potential and Limits for Clinical Trials for Early Alzheimer’s Disease and Some Recommendations. J Nutr Health Aging. 2010;14(4):295–298
Doody RS. Evolving Early (Pre-Dementia) Alzheimer’s Disease Trials: Suit the Outcomes to the Population and Study Design. J Nutr Health Aging. 2010;14(4):299–302.
Petersen RC. Clinical Trials for Early (Pre-Dementia) Alzheimer’s Disease: A Case for Mild Cognitive Impairment. J Nutr Health Aging. 2010;14(4):304–305
Cedarbaum JM, Crans G, Grundman M. Seeing with New Eyes: Finding a Path to Early Intervention Trials in Alzheimer’s Disease. J Nutr Health Aging. 2010;14(4):306–309
Potter WZ. Dose Ranging for Trials through Biomarkers of Drug Effects. J Nutr Health Aging. 2010;14(4):310–311
Schindler RJ. Study Design Considerations: Conducting Global Clinical Trials in Early Alzheimer’s Disease. J Nutr Health Aging. 2010; 14(4):312–314
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vellas, B., Aisen, P.S. Early Alzheimer’s trials: New developments. J Nutr Health Aging 14, 293 (2010). https://doi.org/10.1007/s12603-010-0064-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-010-0064-3